Identification of BATF function and targets during NK cell activation
Identification of BATF function and targets during NK cell activation
批准号:
10354363
负责人:
BARBARA L. KEE
金额:
$20.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-23 至 2023-08-31
关键词:
Activated Natural Killer CellAddressBacteriaBindingBinding SitesCD8-Positive T-LymphocytesCell physiologyCell surfaceCellsChromatinChronicComputer AnalysisCoronavirusCytokine ReceptorsCytokine SignalingDataDiseaseEnvironmentExploratory/Developmental GrantFamilyFoundationsFutureGene ExpressionGenesGenetic TranscriptionGerm LinesGoalsGrantHerpesviridaeHistocompatibilityIRF4 geneImmune responseInfectionInflammatoryInterferon Type IIInterleukin-12Interleukin-18KnowledgeLeadLigandsMalignant - descriptorMetastatic MelanomaMetastatic toMethodsModelingMurid herpesvirus 1MusNK Cell ActivationNatural Killer CellsNeoplasm MetastasisPathogenicityPathway interactionsPhasePlayProductionReceptor SignalingRoleSeriesSignal PathwaySignal TransductionSignaling ProteinSiteSolid NeoplasmStressTestingTherapeuticTimeTranscription Factor AP-1Transcriptional ActivationViral CancerVirusVirus DiseasesXCL1 geneanti-cancercell motilitychemokinecytokinecytotoxicityimmune checkpoint blockadeinsightmelanomamembermigrationnovelpathogenprogramsreceptorresponsetranscription factortranscriptome sequencingtumortumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Natural killer (NK) cells play essential roles in the immune response to intracellular pathogens,
including viruses and bacteria, and form an important defense against malignant transformation
and metastasis. NK cells are activated when they detect an imbalance in the signals from
receptors on their cell surface, either a loss of inhibitory signals or activation through activating
receptors including cytokine receptors. Alterations in these signaling pathways impact the
transcriptional regulatory networks that contribute to NK cell activation and effector function. At
the present time there is a gap in our knowledge of the major transcription factors that are
impacted by these signaling pathways and how they modulate NK cell function. In this R21
application, we present data to support the hypothesis that Batf, the founding member of the
AP-1 family of transcription factors, is induced by proinflammatory cytokine signaling in NK cells
and impacts multiple aspects of the NK cell response. In aim 1, we will test the hypothesis that
Batf regulates key genes involved in NK cell expansion, survival, and effector function by
identifying direct Batf targets during the response to mouse cytomegalovirus. In aim 2, we will
test the hypothesis that Batf plays unique roles in different NK cell activating contexts by testing
the requirement for Batf in the NK cell response to metastatic melanoma and in a solid tumor
model that relies on NK cell migration and chemokine production. Taken together, these studies
will provide a broad view of the requirements for Batf in distinct NK cell activation contexts and
lead to the identification of Batf targets that underlie its essential functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating Helios as a regulator of natural killer cell effector maturation
-
批准号:10608673
-
项目类别:
-
资助金额:$19.76万
-
财政年份:2023
-
负责人:BARBARA L. KEE
-
依托单位:
Identification of BATF function and targets during NK cell activation
-
批准号:10494220
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2021
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
-
批准号:9242168
-
项目类别:
-
资助金额:$39.69万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
-
批准号:10065488
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Molecular Mechanisms of Invariant Natural Killer T Cell Differentiation
-
批准号:10627307
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2016
-
负责人:BARBARA L. KEE
-
依托单位:
Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis
-
批准号:8959799
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2015
-
负责人:BARBARA L. KEE
-
依托单位:
EZH2 in lymphoid lineage specification and commitment
-
批准号:8622415
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10540688
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8791299
-
项目类别:
-
资助金额:$48.39万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8638491
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Regulation of Lymphocyte Development by HLH Proteins
-
批准号:8890271
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10318983
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
EZH2 in lymphoid lineage specification and commitment
-
批准号:8788383
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Natural Killer Cell Development
-
批准号:10084246
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2014
-
负责人:BARBARA L. KEE
-
依托单位:
E and Id protein function in natural killer T cell differentiation
-
批准号:8735243
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2013
-
负责人:BARBARA L. KEE
-
依托单位:
GATA3 deregulation and T cell transformation in E2A-/- mice
-
批准号:8265238
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2011
-
负责人:BARBARA L. KEE
-
依托单位:
GATA3 deregulation and T cell transformation in E2A-/- mice
-
批准号:8189155
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2011
-
负责人:BARBARA L. KEE
-
依托单位:
Mechanisms of Lymphocyte Gene Regulation by E2A and Notch1
-
批准号:7835645
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Hematopoiesis
-
批准号:7742075
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
Transcriptional Control of Hematopoiesis
-
批准号:7897688
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2009
-
负责人:BARBARA L. KEE
-
依托单位:
海外基金